Between COVID-19 severity and its prevention - what should rheumatologists be aware of?
作者信息
Makowska Joanna, Styrzyński Filip
机构信息
Department of Rheumatology, Medical University of Lodz, Poland.
出版信息
Reumatologia. 2021;59(1):1-2. doi: 10.5114/reum.2021.103941. Epub 2021 Feb 28.
Abstract
摘要
相似文献
1
Between COVID-19 severity and its prevention - what should rheumatologists be aware of?在新冠病毒疾病的严重程度与其预防之间——风湿病学家应该注意什么？
Reumatologia. 2021;59(1):1-2. doi: 10.5114/reum.2021.103941. Epub 2021 Feb 28.
2
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey.COVID-19 时代的数字风湿病学：一项全国患者和医生调查结果。
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2020-001548.
3
The impact of COVID-19 on rheumatology practice across Africa.COVID-19 对非洲风湿病学实践的影响。
Rheumatology (Oxford). 2021 Jan 5;60(1):392-398. doi: 10.1093/rheumatology/keaa600.
4
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey.COVID-19 对风湿性疾病脆弱患者的影响：一项全球调查结果。
RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001378.
5
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.羟氯喹在预防新型冠状病毒感染方面的争议使风湿病学家站在了前沿。
RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001323.
6
How and why are rheumatologists relevant to COVID-19?风湿病学家与新冠病毒疾病有怎样的关联，原因又是什么？
Joint Bone Spine. 2020 Jul;87(4):279-280. doi: 10.1016/j.jbspin.2020.04.006. Epub 2020 Apr 30.
7
Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry.抗击新冠疫情需要您的帮助：请为新冠全球风湿病联盟登记处做出贡献。
Int J Rheum Dis. 2021 Jan;24(1):135. doi: 10.1111/1756-185X.14052.
8
Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.风湿病学家和患者对类风湿关节炎中COBRA联合疗法的不同观点。
Rheumatology (Oxford). 2008 Oct;47(10):1571-6. doi: 10.1093/rheumatology/ken323. Epub 2008 Aug 18.
9
Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.羟氯喹：COVID-19大流行期间风湿病学家面临的潜在伦理困境。
J Rheumatol. 2020 Jun 1;47(6):783-786. doi: 10.3899/jrheum.200369. Epub 2020 Apr 2.
10
The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists.皮肤科医生、风湿病学家和神经科医生对皮肤型皮肌炎疾病面积和严重程度指数（CDASI）的可靠性。
Br J Dermatol. 2017 Feb;176(2):423-430. doi: 10.1111/bjd.15140. Epub 2016 Dec 22.
引用本文的文献
1
Serological response after COVID-19 infection compared to vaccination against COVID-19 in children with autoimmune rheumatic diseases.儿童自身免疫性风湿病患者感染 COVID-19 后的血清学反应与接种 COVID-19 疫苗的比较。
Pediatr Rheumatol Online J. 2024 Jul 25;22(1):68. doi: 10.1186/s12969-024-01003-0.
2
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.儿童自身免疫性风湿病患者 COVID-19 感染和疫苗接种后的疾病复发率。
Pediatr Rheumatol Online J. 2023 May 19;21(1):46. doi: 10.1186/s12969-023-00829-4.
3
Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis.SARS-CoV-2 感染对系统性幼年特发性关节炎的影响。
Int J Mol Sci. 2022 Apr 12;23(8):4268. doi: 10.3390/ijms23084268.
4
COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity.青少年特发性关节炎患者中的新型冠状病毒肺炎：发病率与严重程度
Reumatologia. 2021;59(3):197-199. doi: 10.5114/reum.2021.107590. Epub 2021 Jul 11.
本文引用的文献
1
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
2
3
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.风湿性疾病患者 COVID-19 相关死亡的相关因素：来自 COVID-19 全球风湿病联盟医生报告登记处的结果。
Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27.
4
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.欧洲过敏与临床免疫学会关于严重 COVID-19 疫苗过敏反应的诊断、管理和预防的声明
Allergy. 2021 Jun;76(6):1629-1639. doi: 10.1111/all.14739.
5
COVID-19: What Do Rheumatologists Need to Know?COVID-19：风湿病学家需要了解什么？
Curr Rheumatol Rep. 2021 Jan 5;23(1):5. doi: 10.1007/s11926-020-00971-y.
6
Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study.风湿性疾病患者中重症 COVID-19 结局的时间趋势：一项队列研究。
Lancet Rheumatol. 2021 Feb;3(2):e131-e137. doi: 10.1016/S2665-9913(20)30422-7. Epub 2020 Dec 24.
7
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.COVID-19 严重程度与风湿和炎症性疾病患者的生存：来自法国 RMD COVID-19 队列的 694 例患者的数据。
Ann Rheum Dis. 2021 Apr;80(4):527-538. doi: 10.1136/annrheumdis-2020-218310. Epub 2020 Dec 2.
8
COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.中国湖北省风湿性疾病患者的新冠肺炎：一项多中心回顾性观察研究
Lancet Rheumatol. 2020 Sep;2(9):e557-e564. doi: 10.1016/S2665-9913(20)30227-7. Epub 2020 Jul 3.
9
The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic.新冠疫情时代波兰风湿病患者对远程医疗的态度。
Reumatologia. 2020;58(3):134-141. doi: 10.5114/reum.2020.96665. Epub 2020 Jun 29.
10
Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.类风湿关节炎患者季节性流感疫苗接种免疫原性：停用甲氨蝶呤 2 周的影响：一项随机临床试验。
Ann Rheum Dis. 2018 Jun;77(6):898-904. doi: 10.1136/annrheumdis-2018-213222. Epub 2018 Mar 23.
Zotero 插件